Clinical trials
Neoplasms clinical trials
Below are recruiting neoplasms clinical trials, each written for real people, not researchers. We’re tracking 1,642 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05245877RecruitingPhase 4
Preventing blood clots before and after pancreatic surgery
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
TorontoAges 18–120 - NCT07404605Recruiting
Electrochemotherapy for skin melanoma study
This study tests if electrochemotherapy can change the environment around melanoma tumors. It may help patients with melanoma that has spread to the skin or just under the skin.
LjubljanaAges 18 years+ - NCT07401641Recruiting
Pain control study for oral cancer surgery
This study tests two different pain medicines (dezocine or nalbuphine) combined with sufentanil to see which helps better control pain after oral cancer surgery with free flap reconstruction. It also looks at side effects and how well the transplanted tissue survives.
Guangzhou, GuangdongAges 18–70 - NCT07405099Enrolling by invitation
Pancreas surgery risks in kidney failure patients
This study looks at the risks of pancreas surgery in people with end-stage kidney disease (kidney failure). It aims to help doctors understand how safe these surgeries are for patients on dialysis or with kidney problems.
Ages 20–75 - NCT07398599Recruiting
Double-dose targeted therapy plus chemo for lung cancer spread to brain lining
This trial tests a stronger dose of an EGFR-targeted drug combined with bevacizumab and chemotherapy into the spinal fluid for patients with non-small cell lung cancer that has spread to the lining of the brain and is no longer responding to standard treatment.
Nanchang, JiangxiAges 18–99 - NCT06318507Recruiting
Gut Bacteria and Immunotherapy for Triple-Negative Breast Cancer
This study looks at how bacteria in your gut might affect the way your body responds to immunotherapy for triple-negative breast cancer. It focuses on women who are overweight or obese and are about to start treatment with pembrolizumab before surgery.
Baton Rouge, LouisianaAges 18 years+ - NCT06830512Recruiting
Ultrasound-guided radiofrequency ablation for heart tumors
This trial tests a procedure that uses ultrasound images to guide a thin needle into the heart to destroy tumors with heat. It is for people who have heart tumors causing symptoms but cannot have standard surgery.
Xi'an, ShannxiAges Any age - NCT07391345Recruiting
MRI-Guided Radiation for Early Vocal Cord Cancer
This study tests a precise, MRI-guided radiation treatment for early-stage vocal cord cancer. It aims to deliver high-dose radiation more accurately to the tumor, possibly reducing side effects and improving outcomes.
KaunasAges 18 years+ - NCT07396662Recruiting
Pancreas Function and Recovery After Surgery
This study looks at how well the pancreas works (both hormone and digestive functions) and what happens to patients after pancreas removal surgery. It may help doctors better predict recovery and long-term health.
Taipei, TaiwanAges 20–75 - NCT07396896Recruiting
A study on brain tumors and weight gain after treatment
This trial tests a diet therapy for young people who have gained a lot of weight after treatment for a certain type of brain tumor. The goal is to see if the diet can help manage obesity related to the tumor or its treatment.
Florence, FlorenceAges 7–30 - NCT07397611RecruitingPhase 2
Neoadjuvant immunotherapy for clear cell kidney cancer
This study tests a new combination of medications (casdatifan and zimberelimab) given before surgery to remove kidney tumors in people with clear cell renal cell carcinoma (ccRCC). The goal is to see if this approach can help shrink the tumor or improve outcomes.
Boston, MassachusettsAges 18 years+ - NCT06242119Recruiting
Testing a new PET scanner prototype
This study is testing a new type of PET scanner (called J-PET) to see if it works as well as current PET/CT machines. If you are already scheduled for a whole-body PET/CT scan, participating would mean your scan is done with this experimental scanner instead.
KrakowAges 18 years+ - NCT06756061RecruitingPhase 2
Ruxolitinib and steroids for chronic graft-versus-host disease
This trial tests whether adding ruxolitinib to standard steroid treatment works better than steroids alone for people with moderate to severe chronic graft-versus-host disease (cGVHD). cGVHD is a condition where donor immune cells attack the body after a stem cell transplant.
Seoul, Banpo-daero/Seocho-guAges 19 years+ - NCT06266312Recruiting
Lifestyle program before breast cancer surgery
This study tests whether a program of healthy eating, exercise, and stress management before breast cancer surgery is practical and helpful for patients who will receive chemotherapy first. It aims to see if a lifestyle plan can improve your well-being during treatment.
Maastricht, LimburgAges 18 years+ - NCT07382791Recruiting
Stomach emptying after pancreas surgery
This study looks at how the stomach empties after pancreas surgery. It aims to understand and possibly help with slow stomach emptying, a common issue after this operation.
Taipei, TaiwnAges 20–75 - NCT07387445Recruiting
Time-Restricted Eating During Breast Cancer Chemotherapy
This trial tests whether eating only during certain hours of the day (time-restricted eating) is doable and helpful for people receiving chemotherapy for breast cancer. The goal is to see if this eating pattern can be a safe way to support your health during treatment.
Chicago, IllinoisAges 25–99 - NCT06840418Recruiting
New imaging to find cancer spread in cervical cancer surgery
This study tests a new imaging technique (NIRFI with ICG dye) to help surgeons see if cervical cancer has spread to lymph nodes during your hysterectomy surgery. It may help guide more precise removal of affected nodes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07378709Recruiting
Blood markers for TACE-treated liver cancer
This study is looking for blood markers that may help doctors learn how well TACE treatment is working for liver cancer. You need to be scheduled for TACE and have a follow-up scan to participate.
BelgradeAges 18 years+ - NCT07378670Recruiting
Surgery for penile cancer: comparing two groin lymph node removal approaches
This study compares two ways of removing lymph nodes in the groin to treat or prevent the spread of penile cancer. It looks at which surgery might be safer and more effective for patients with early to moderate stage disease.
BerlinAges 18 years+ - NCT07372248Recruiting
Heat effect study for cervical treatment (LLETZ)
This study tests how heat affects cervical tissue removed during a LLETZ procedure for abnormal cells. If you need LLETZ, the results could help doctors improve future treatments.
AdanaAges 18 years+ - NCT07378930Recruiting
ULTRA-SAFE: More frequent monitoring after advanced polyps
This trial compares a new, more frequent surveillance schedule (yearly stool tests and colonoscopies every 2 years) to the standard schedule for people who have had advanced polyps removed. It aims to see if the extra testing helps prevent future colon cancer.
Taipei, TaipeiAges 40–75 - NCT07378423Recruiting
Survey on signs of cancer at birth
This trial asks newly diagnosed children and young adults with certain types of cancer to fill out a questionnaire about signs of cancer present at birth. The answers may help improve early detection of childhood cancer.
BernAges Up to 21 years - NCT07377487Recruiting
TheraSphere for liver cancer before market in Japan
This trial tests a treatment called TheraSphere for people with liver cancer that hasn't responded to standard care or can't have it. TheraSphere uses tiny radioactive beads to target tumors in the liver, and this study is being done to get it approved in Japan.
Nishinomiya, HyōgoAges 18 years+ - NCT04271644RecruitingPhase 1/Phase 2
CAR-T treatment targeting BCMA for hard-to-treat myeloma
This Phase 1/2 study tests a BCMA-targeting CAR-T cell therapy for people with relapsed or refractory multiple myeloma or related plasma cell diseases. It may help by using your own immune cells, engineered to recognize a specific target on cancer cells.
Kunming, YunnanAges 18–75
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasms?
- Yes. Clin2 currently lists 1,642 recruiting neoplasms studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasms trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasms trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.